See every side of every news story
Published loading...Updated

5 years on ofatumumab

Tweet Ofataumumab is an anti CD20 antibody injected under the skin. It inhibits relapsing MS and 5 years later is still doing the same. The selling point is that this can be done at home and that it inhibits progressive disability says that the central driver for this is due to stopping B cells getting in the brain. I say this because I am not convinced the antibody gets in the brain the blood levels are about 4 microgramme a millilitre so a tho…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Multiple Sclerosis Research Blog broke the news in on Monday, July 14, 2025.
Sources are mostly out of (0)